APA (7th ed.) Citation

Southam, E., Cilia, J., Gartlon, J., Woolley, M., Lacroix, L., Jennings, C., . . . Jones, D. (2009). Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040. Psychopharmacology, 201(4), 483. https://doi.org/10.1007/s00213-008-1310-9

Chicago Style (17th ed.) Citation

Southam, Eric, et al. "Preclinical Investigations into the Antipsychotic Potential of the Novel Histamine H3 Receptor Antagonist GSK207040." Psychopharmacology 201, no. 4 (2009): 483. https://doi.org/10.1007/s00213-008-1310-9.

MLA (9th ed.) Citation

Southam, Eric, et al. "Preclinical Investigations into the Antipsychotic Potential of the Novel Histamine H3 Receptor Antagonist GSK207040." Psychopharmacology, vol. 201, no. 4, 2009, p. 483, https://doi.org/10.1007/s00213-008-1310-9.